Maze Therapeutics, Inc. (MAZE)
41.11
-0.28
(-0.68%)
USD |
NASDAQ |
Jan 14, 16:00
41.00
-0.11
(-0.27%)
Pre-Market: 08:17
Maze Therapeutics Market Cap: 1.978B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CDT Equity, Inc. | 2.281M |
| LENZ Therapeutics, Inc. | 581.68M |
| Liminatus Pharma, Inc. | 20.30M |
| Oruka Therapeutics, Inc. | 1.549B |
| MapLight Therapeutics, Inc. | 851.20M |
Market Cap Related Metrics
| PEG Ratio | -1.262 |
| Price to Book Value | 5.214 |
| Price | 41.11 |
| Earnings Yield | -5.48% |
| PEGY Ratio | -1.262 |